Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen

被引：0
|
作者：
Grisariu, S. [1 ]
Shapira, M. Y. [1 ]
Or, R. [1 ]
Avni, B. [1 ]
机构：
[1] Hadassah Med Ctr, Bone Marrow Transplantat, IL-91120 Jerusalem, Israel
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P613
引用
收藏
页码：S441 / S441
页数：1
相关论文
共 50 条
  • [31] Phase I study for poor prognosis lymphoma: Modification of the "BEAM" (BCNU plus Etoposide plus ARA-C plus Melphalan) regimen with escalating-dose melphalan (MEL) using amifostine (AF) cytoprotection and autologous hematopoietic stem cell transplantation (AHSCT).
    Phillips, Gordon L.
    Abboud, Camille N.
    Bernstein, Steven H.
    Friedberg, Jonathan W.
    Becker, Michael W.
    Ifthilkharuddin, Jainulabdeen J.
    Young, Faith
    Liesveld, Jane L.
    BLOOD, 2006, 108 (11) : 876A - 876A
  • [32] Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
    Zhang, Lihong
    Yang, Haifei
    Qian, Chongsheng
    Zhou, Jihao
    Zhu, Qian
    Jiang, Yibin
    Liu, Shuo
    Chen, Xiaochen
    Xu, Ting
    Qu, Changju
    Li, Caixia
    Jin, Zhengming
    Chu, Jianhong
    Zhang, Xinyou
    Wu, Depei
    Huang, Haiwen
    HEMATOLOGY, 2022, 27 (01) : 404 - 411
  • [33] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
  • [34] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [35] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 116 - 117
  • [36] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Sivaraj, D.
    Bacon, W.
    Long, G. D.
    Rizzieri, D. A.
    Horwitz, M. E.
    Sullivan, K. M.
    Kang, Y.
    Li, Z.
    Chao, N. J.
    Gasparetto, C.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 34 - 38
  • [37] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Song, Ga-Young
    Jung, Sung-Hoon
    Kim, Mihee
    Ahn, Seo-Yeon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Hyeong-Joon
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Moon, Joon Ho
    Yhim, Ho-Young
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S157 - S158
  • [38] Busulfan and thiotepa conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Hyeoung-Joon
    Kim, Jin Seok
    Kim, Kihyun
    Eom, Hyeon-Seok
    Yhim, Ho-Young
    Lee, Yoo Jin
    Hyun, Shin Young
    Lee, Je-Jung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 226 - 226
  • [39] Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma
    Scortechini, Ilaria
    Montanari, Mauro
    Mancini, Giorgia
    Inglese, Elena
    Calandrelli, Monica
    Chiarucci, Martina
    Offidani, Massimo
    Capelli, Debora
    Gini, Guido
    Poloni, Antonella
    Mancini, Stefania
    Raggetti, Gianmario
    Leoni, Pietro
    Olivieri, Attilio
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1657 - 1660
  • [40] Efficacy of olanzapine-containing prophylactic antiemetic regimen in autologous hematopoietic stem cell transplantation patients who undergo conditioning with thiotepa, busulfan and cyclophosphamide
    Jung, Youree
    Kim, Bobae
    Shin, Eunjeong
    Suh, Sungyun
    Cho, Yoonsook
    Lee, Juyeun
    Koh, Youngil
    BONE MARROW TRANSPLANTATION, 2018, 53 : 323 - 323
12345